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Incomplete knowledge of the mechanisms at work
continues to hamper efforts to maximize reprog-
ramming efficiency. Here, we present a systematic
genome-wide RNAi screen to determine the global
regulators during the early stages of human reprog-
ramming. Our screen identifies functional repressors
and effectors that act to impede or promote the
reprogramming process. Repressors and effectors
formclose interactingnetworks inpathways, including
RNA processing, G protein signaling, protein ubiquiti-
nation, and chromatin modification. Combinatorial
knockdown of five repressors (SMAD3, ZMYM2,
SFRS11, SAE1, and ESET) synergistically resulted inCell
This is an open access article under the CC BY-N85% TRA-1-60-positive cells. Removal of the novel
splicing factor SFRS11 during reprogramming is
accompanied by rapid acquisition of pluripotency-
specific spliced forms.Mechanistically, SFRS11 regu-
lates exon skipping andmutually exclusive splicing of
transcripts in genes involved in cell differentiation,
mRNAsplicing,andchromatinmodification.Ourstudy
provides insights into the reprogramming process,
which comprises comprehensive and multi-layered
transcriptional, splicing, and epigenetic machineries.
INTRODUCTION
The overexpression of the transcription factors (TFs) OCT4,
SOX2, KLF4, and c-MYC (OSKM) has been shown to convertReports 15, 2597–2607, June 21, 2016 ª 2016 The Author(s). 2597
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Genome-wide siRNA Screen Identifies Regulators of Human Reprogramming
(A) Schematic of reprogramming timeline and temporal cell samples collected for analysis. Reprogramming intermediates on 5 d.p.i. (d5I), 8 d.p.i. (d8I), 12 d.p.i.,
and 16 d.p.i. were harvested for mRNA-seq. 12 d.p.i. and 16 d.p.i. cells were sorted by the TRA-1-60 marker into positive (d12T+, d16T+) and negative (d12T,
d16T) populations.
(B) Ranked distribution plot for the genome-wide siRNA screen. 599 genes with Z scores of >1.65 are considered potential candidates that are repressor of
reprogramming (red dots). 557 genes with Z scores of < 1.3 are considered potential candidate effectors of reprogramming (green dots). The rest of the genes
are indicated as gray dots.
(C) Representative images of TRA-1-60 (green) and DNA (blue) for selected hits identified from the genome-wide screen.
(D) Secondary screen of 76 genes with a second marker for pluripotency (TRA-1-81). Each row represents the knockdown of a single repressor, effector or NT
control. Each column represents individual replicate experiments.
(legend continued on next page)
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somatic cells into induced pluripotent stem cells (iPSCs) (Park
et al., 2008; Takahashi and Yamanaka, 2006; Takahashi et al.,
2007; Yu et al., 2007). Biochemical and genetic dissection of
the molecular mechanisms underlying TF-induced reprogram-
ming has been hampered by its low efficiency, slow kinetics,
and the fact that it proceeds via heterogeneous intermediate
cell populations (Polo et al., 2012; Stadtfeld and Hochedlinger,
2010). Nonetheless, recent studies have indicated that reprog-
ramming is a stepwise process with at least three distinct
phases: initiation, maturation, and stabilization (Samavarchi-
Tehrani et al., 2010), with each phase marked by unique epige-
nomic and transcriptomic changes (Buganim et al., 2012; Polo
et al., 2012). Several key cellular events, such as cell-cycle mod-
ulations (Kawamura et al., 2009; Qin et al., 2012; Zhao et al.,
2008) and mesenchymal-to-epithelial transitions (Li et al.,
2010; Samavarchi-Tehrani et al., 2010), were reported to influ-
ence reprogramming efficiency. In addition, the activity of epige-
netic regulators, such as H3K9 methyltransferases (Chen et al.,
2013) (EHMT1, SETDB1) and a H3K79 methyltransferase (Onder
et al., 2012) (DOT1L), were found to limit the efficiency of
reprogramming.
Recent attempts to attain a comprehensive overview of
players involved in reprogramming utilized a pooled small hairpin
RNA (shRNA) approach to conduct functional genome-wide
screens in both mouse (Yang et al., 2014) and human (Qin
et al., 2014) fibroblast lines. However, the constitutive knock-
down of targeted genes by shRNA renders such screens unsuit-
able in the identification of key regulators affecting only a specific
stage of themultiphasic reprogramming process (Buganim et al.,
2012; Polo et al., 2012; Samavarchi-Tehrani et al., 2010).
To systematically identify genetic factors involved in early-
phase reprogramming, we developed a high-throughput reprog-
ramming assay adapted to a 384-well format for genome-wide
small interfering RNA (siRNA) screening. This screening strategy
allowed for transient knockdowns within a specific reprogram-
ming phase, allowing us to identify phase-specific factors whose
effects might be otherwise masked due to constitutive expres-
sion of the integrated shRNA.
RESULTS
Systematic Genome-wide siRNA Screen Identifies
Functional Effectors and Repressors of Reprogramming
To identify the functional switches of early reprogramming,
siRNA-mediated gene knockdown was performed on day 5
postinfection (5 d.p.i.) with lentiviral OSKM (Figure 1A). ESET
(Chen et al., 2013) and OCT4 were selected as controls to opti-
mize an unbiased genome-wide siRNA screen (Figure S1A). A
preliminary screen for 972 human kinases and phosphatases
was performed to demonstrate the robustness and reproduc-
ibility of the assay (Figures S1B–S1E; Table S1). We then pro-
ceeded with the genome-wide screen, targeting 21,121 human(E) Validation of candidate genes in a retroviral reprogramming system. The area
obtained with reference to a siNT2 negative control. n = 4; error bar indicates SD
(F) Validation of selected candidates assayed at 21 d.p.i. Left: representative im
number of colonies stained with TRA-1-60. The gray dashed line indicates the repgenes (Figures 1B, 1C, and S1F). The average Z0 factor from
two biological replicates of the genome-wide screen was 0.35
for siESET and 0.37 for siOCT4. It was reassuring that our screen
detectedOCT4 and ESET as the top effector and repressor of re-
programming, respectively (Figure 1B). Additionally, we identi-
fied several previously reported regulators, including TGFBR2
(Ichida et al., 2009; Lin et al., 2009; Shi et al., 2008), ROCK1
(Lai et al., 2010; Subramanyam et al., 2011), MBNL1 (Han
et al., 2013), SALL4 (Tsubooka et al., 2009), c-MYC (Sama-
varchi-Tehrani et al., 2010), and SOX2 (Samavarchi-Tehrani
et al., 2010) (Figure 1B). Based on a targeted error rate of 0.05,
a cutoff of +1.65 and 1.3 was used to identify 599 putative re-
pressors and 557 putative effectors (Figures 1B and 1C; Table
S1) (Birmingham et al., 2009). Gene Ontology (GO) analysis of
these candidate repressors and effectors showed enrichment
of multiple biological processes and pathways (Figures S1G
and S1H). Next, we randomly selected 76 putative regulators
for secondary screens. Selected regulators consistently repro-
duced their reprogramming phenotype when an independent
pluripotent marker (TRA-1-81) was utilized (Figures 1D and
S1I). Based on the Z score obtained from the genome-wide
screen, we validated the top ten repressors and top five effectors
in a different retroviral reprogramming system (Figure 1E). These
regulators consistently affected reprogramming efficiencies
when the assay was extended to 21 d.p.i. (Figure 1F). Pooled
siRNA for the top repressors were then deconvoluted into the
individual siRNAs and each recapitulated the effect on reprog-
ramming (Figure S1J). To identify bona fide regulators of reprog-
ramming, the Z score was normalized to nuclei number to
remove the effect of proliferation on assay readout. Unlike the
knockdown of P53, siRNA of SAE1, SFRS11, ZMYM2, SMAD3,
and ESET did not significantly affect cell proliferation (Figures
S1K and S1L).
Combinatorial Removal of Repressors Allows for High
Reprogramming Efficiencies
The strongest repressors—namely SMAD3 (transforming growth
factor b [TGF-b] signal transducer), ZMYM2 (epigenetic modi-
fier), SFRS11 (putative splicing factor), SAE1 (Sumo-activating
enzyme), and ESET (H3K9 methyltransferase) —function in
distinct pathways. Therefore, we hypothesize that each factor
is an independent barrier against reprogramming. As expected,
the pairwise knockdown of two repressors had an additive effect
on reprogramming enhancement (Figure 2A). We then pooled
the siRNAs against repressors in groups of five (ESET,
ZMYM2, SAE1, SFRS11, and SMAD3) or eight (si5, PAFAH2,
FRAS1, and SSNA1). The combinatorial knockdown of five
(si5) or eight (si8) repressors enhanced reprogramming several
fold as compared to the removal of individual repressors (Figures
2B and 2C). In addition, si5 depletion enhanced the formation of
iPSCs in multiple reprogramming systems and parental cell lines
(Figures S2A–S2C). As DOT1L and TGF-b signaling pathwaysof each marker stained was normalized to cell number, and the Z score was
.
ages of TRA-1-60 staining. n = 3; error bar indicates SD. Right: graph of the
rogramming efficiency of negative control (siNT). n = 3; error bar indicates SD.
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Figure 2. Combinatorial Knockdown of Repressors Synergistically Increases Reprogramming Efficiency
(A) Heatmap of the TRA-1-60 signal at 12 d.p.i., when two candidates were depleted simultaneously. n = 8.
(B) Removal of multiple repressors allows high reprogramming efficiency. Reprogramming was assayed at 16 d.p.i. All combinations of siRNA were reverse
transfected with equimolar amounts of different siRNA. n = 8; error bars indicate SD.
(C) Representative images of TRA-1-60 (green) and DNA (blue) for the knockdown of repressors singly or in combination.
(D) Repressors function independently from the DOT1L pathway. Left: representative images of TRA-1-60+ colonies on 12-well plates after knockdown of the
indicated genes. Right: bar graph indicating the number of TRA-1-60+ colonies obtained at 21 d.p.i. n = 3; error bar indicates SD.
(E) Repressors function independently of the TGF-b pathway. Left: representative images of TRA-1-60+ colonies on 12-well plates after knockdown of the
indicated genes. Right: bar graph indicating the area of TRA-1-60 staining obtained at 21 d.p.i. n = 3; error bar indicates SD.
(F) si5 in combination with OSKML (LIN28) induction and TGF-b inhibition increase reprogramming yield. Bar graph of the percentage of cells that stained positive
for TRA-1-60 at 28 d.p.i. The highest reprogramming efficiency (82.75%) was observed with the inhibition of TGF-b and si5, with the simultaneous overexpression
of LIN28. n = 3; error bar indicates SD.
(legend continued on next page)
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were previously implicated as critical barriers of reprogramming,
we examined the effect of inhibiting these pathways upon si5
depletion. The inhibition of DOT1L and TGF-b signaling further
enhanced reprogramming, suggesting that the repressors’ effect
on reprogramming is at least partially independent of DOT1L and
TGF-b signaling (Figures 2D and 2E). The combined inhibition of
DOT1L or TGF-b with si5 allowed most cells to undergo homog-
enous morphological changes, resulting in rapid development of
reprogrammed colonies (Figures 2D, 2E, and S2D). The ectopic
expression of OSKM+L (LIN28), coupled with the depletion of si5
and TGF-b signaling, resulted in the generation of85% TRA-1-
60+ cells at 28 d.p.i. (Figures 2F and S2E). Moreover, si5 deple-
tion could replace c-MYC in the reprogramming cocktail (Fig-
ure 2G). iPSC lines obtained from si5 knockdown share similar
characteristics with human embryonic stem cells (hESCs) and
have normal chromosomal karyotypes (Figures 2H, 2I, and
S2F–S2I). Taken together, these data demonstrate that the
simultaneous removal of these repressors allows reprogram-
ming to proceed in a more deterministic manner.
Knockdown of Regulators Affects Dynamics of
Reprogramming
To understand the underlying mechanisms of the identified
reprogramming regulators, we performed mRNA sequencing
(mRNA-seq) on cells undergoing reprogramming (Figure 1A;
Table S2). Differential GO analysis shows the shift of biological
functions associated with fibroblasts toward processes that
define pluripotency (Figure 3A). Additionally, transcriptome re-
wiring is accompanied by a progressive epigenetic shift toward
bivalency on lineage-associated genes and the activation of plu-
ripotency genes (Figures S3A and S3B). Gene set enrichment
analysis (GSEA) and principal-component analysis (PCA) illus-
trate the progressive shift toward the iPSC fate (Figure S3C).
To determine if the knockdown of repressors accelerates re-
programming, we examined the kinetics of SSEA4 and TRA-1-
60 expression. The knockdown of repressors (siRepressor)
accelerated the detection of TRA-1-60 to as early as 8 d.p.i. (Fig-
ures 3B and S3D). Correspondingly, siRepressor accelerated the
acquisition of a transcriptome profile closer to that of more
advanced reprogrammed cells (Figures 3C–3E). siRepressor
consistently resulted in higher expression of pluripotency-asso-
ciated genes and lower expression of fibroblast-associated
genes at earlier time points (Figures 3D–3F and S3E). The repres-
sion of epithelial-to-mesenchymal transition (EMT)-associated
genes and activation of mesenchymal-to-epithelial transition
(MET)-associated genes were accelerated in siRepressor sam-
ples (Figures 3E, 3F, and S3E). The differential expression anal-
ysis of the selected regulators resulted in transcriptome profiles
that are unique to each knockdown condition (Figures S3F and
S3G). This affirms the presence of distinctivemechanistic effects
by which these regulators drive or deter reprogramming.(G) Combinatorial depletion of si5 can replace c-MYC in the reprogramming cock
White arrows indicate forming colonies.
(H) Antibody staining of the si5c1 iPSC line shows that they express markers of p
and DNA (blue).
(I) Bisulfite DNA methylation analysis on the promoter of OCT4 and NANOG in si
used as controls. The white and black circles represent unmethylated and methSFRS11 Regulates Alternative Splicing during
Reprogramming
Within the si5 combination, siSFRS11 contributed most of the
increased reprogramming efficiency (Figures S4A and S4B).
Moreover, SFRS11 is one of the strongest repressors (Figures
1E, 1F, and 2B–2E) in the majority of validation assays. We
therefore focused on deciphering the mechanism through
which SFRS11 represses reprogramming. siSFRS11-derived
iPSC clones had characteristics similar to hESC lines (Figures
S4C–S4E) and the capacity to form teratomas in immunodefi-
cient mice (Figure S4F). Interestingly, SFRS11 depletion had
no effect on pluripotency (Figures S4G and S4H) (Chia et al.,
2010). These data suggest that SFRS11 specifically regulates
the acquisition, but not maintenance, of pluripotency. Addition-
ally, clustered regularly interspaced short palindromic repeats
(CRISPR)/Cas9-mediated knockout of SFRS11 also enhanced
reprogramming efficiency, further confirming the repressive
effects of SFRS11 on reprogramming (Figure S4I).
To gain mechanistic insights into the role of SFRS11,
we analyzed deep mRNA-seq of the SFRS11- and SMAD3-
depleted (non-splicing repressor control) reprogramming cells
at 8 d.p.i. Exon inclusion and de novo transcript assembly
analyses showed that SFRS11 knockdown resulted in drastic
changes in differential isoform expression (Figures 4A, 4B,
and S4J). Reads were mapped to exon-splice junction sites
and analyzed to identify different splicing events. Depletion
of SFRS11 resulted in a change in 696 splicing events (489
genes), whose inclusion ratio indicated significant splicing
(false discovery rate [FDR] < 0.01) when compared to the
non-targeting siRNA (siNT) control (Table S3). In contrast,
SMAD3 knockdown resulted in a change of 43 splicing events
(33 genes, FDR < 0.01). SFRS11 regulates the alternative
splicing of genes that were enriched with several biological
process, including cell differentiation, cell proliferation, pro-
grammed cell death, mRNA splicing, and chromatin modifica-
tions (Figure 4C).
Out of these splicing events, four splicing patterns can be
observed (Figures 4D, S4K, and S4L). Exon skipping (62.4%)
and mutually exclusive (16.4%) events account for the majority
of events detected upon SFRS11 depletion (Table S3). The
depletion of SFRS11 predominantly increased the inclusion of
skipped exons (Figure 4E) and of downstreammutually exclusive
exons (Figure 4F). To validate these alternatively spliced events,
we performed PCR for regions flanking skipped exons or mutu-
ally exclusive exons. Gel electrophoresis and band intensity
analysis enable us to obtain the relative proportion of each alter-
natively spliced exon that differed in size. We validated four
exon-skipping and four mutually exclusive splicing events at
different time points of the reprogramming process. Interest-
ingly, SFRS11 depletion resulted in splicing isoforms that are
closer to the pluripotent state (Figures 4G and S4M). Thesetail. Bright-field images of reprogramming BJ fibroblasts at 28 d.p.i. are shown.
luripotent stem cells, namely TRA-1-81 (white), TRA-1-60 (green), OCT4 (red),
5c1 iPSCs. siNTc1 iPSC cell line, parental BJ fibroblasts, and H1 hESCs were
ylated CpG islands in the promoter region, respectively.
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Figure 3. Perturbation of Repressors and Effectors Affects Reprogramming Kinetics
(A) Differential GO analysis for different stages of reprogramming. Darker red represents higher significance.
(B) siRepressor knockdown accelerate reprogramming kinetics. Immunostaining of TRA-1-60 (green), SSEA4 (red), and DNA (blue) at different days of
reprogramming as indicated.
(legend continued on next page)
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results suggest that specific splicing events could repress or
promote reprogramming.
SFRS11 Regulates Splicing of Reprogramming Effector
ZNF207
From exon-skipping events, we identified ZNF207 to be a puta-
tive downstream splicing target of SFRS11 during the early
phase of reprogramming (Figures 4E and 4G). The mouse homo-
log zfp207 was reported to undergo alternative splicing during
mouse reprogramming (Ohta et al., 2013). We first validated
that the splicing of ZNF207 was specific to SFRS11 depletion
and not due to the accelerated reprogramming kinetics (Fig-
ure 4H). Depletion of SFRS11 increased levels of ZNF207 iso-
form A and C transcripts while decreasing isoform B transcripts,
corresponding to the increased retention of exon 9 (Figure 4H).
To understand the interaction between SFRS11 and ZNF207,
we deleted the two functional domains of SFRS11, namely the
RNA-recognition motif (RRM) that confers the ability to bind to
single-stranded RNA and an arginine-serine rich domain (RS)
that facilitates protein-protein interactions (Lunde et al., 2007)
(Figures S4N and S4O). Consistent with the repressive pheno-
type observed from siRNA-mediated knockdown, overexpres-
sion of wild-type (WT) SFRS11 dramatically repressed reprog-
ramming (p < 0.05). In contrast, mutation of either the RRM
(DRRM) or the RS (DRS) domain partially rescued the repressive
effects of SFRS11 (Figure 4I). We then asked if ZNF207 tran-
scripts were directly regulated by SFRS11 by performing ultravi-
olet crosslinking coupled to immunoprecipitation and qPCR
(CLIP-qPCR) in cells undergoing reprogramming (8 d.p.i.). We
confirmed that SFRS11 binds directly to endogenous ZNF207
transcripts via its RRM domain (Figures 4J, 4K, and S4P). Detec-
tion of ZNF207 transcripts was only possible when antibody
against WT SFRS11 was used in the immunoprecipitation (Fig-
ures 4J and 4K).
We next asked if the overexpression of individual ZNF207 iso-
forms affects reprogramming efficiency. Interestingly, the over-
expression of ZNF207 isoforms A and C consistently enhanced
reprogramming efficiency by 1.12- and 1.5-fold, respectively
(p < 0.05), while overexpression of the ZNF207 isoform B
decreased reprogramming efficiency to 0.7-fold (p < 0.05) (Fig-
ure 4L). The knockdown of all three ZNF207 isoforms using
siRNA decreased overall reprogramming efficiency dramatically
(Figure S4Q). We therefore designed steric hindrance antisense
oligonucleotides (AONs) to induce specific skipping of either
ZNF207 exons 6 or 9 (Figure 4H), resulting in the specific switch-
ing of ZNF207 isoform C to A (AON 1 and 2) or switching of
ZNF207 isoform A and C to B (AON 3–5) (Figures S4R and
S4S; Table S4). The introduction of these AONs reduced
ZNF207 isoform C (Figures S4R and S4S) during reprogram-(C) Principal-component analysis (PCA) of RNA-sequencing libraries (refer to
pluripotent state. Day 12 and 16 samples are sorted with TRA-1-60.
(D) Dynamic expression of genes that are differentially expressed between fibro
samples demonstrate a higher rate of downregulation of fibroblast-associated g
(E) Heatmap demonstrating dynamic expression of the indicated genes clustered
late stages (III) of reprogramming. Genes belonging to EMT (M) and MET (E) are
(F) qRT-PCR quantification of pluripotency (ERRB3, NANOG, ZFP42), mesen
normalized to H1 hESCs. n = 2; error bars indicate SD.ming, resulting in a decrease in reprogramming efficiency
(p < 0.001). As AON 3–5 promotes the switching of ZNF207
isoform C to isoform B, the increased of ZNF207 isoform
B expression further reduces reprogramming efficiency as
compared to AON 1 and 2 (p < 0.001) (Figures S4R and S4S).
These data support the results of the overexpression studies,
showing that an increase in ZNF207 isoforms A and C is crucial
for reprogramming whereas an increase in ZNF207 isoform B
hinders reprogramming.
DISCUSSION
Somatic cell reprogramming proceeds through ordered and
distinct phases of initiation, maturation, and stabilization (Goli-
pour et al., 2012; Samavarchi-Tehrani et al., 2010). We have
developed a sensitive high-throughput screen assay, which
enabled us to systematically unravel 599 repressors and 557 ef-
fectors of the early phase of reprogramming, including estab-
lished and previously undescribed regulators (Onder et al.,
2012; Qin et al., 2014; Rais et al., 2013; Samavarchi-Tehrani
et al., 2010; Yang et al., 2014). Expectedly, the importance of
OSMduring early reprogramming was highlighted by our screen,
consistent with a previous focused screen performed in the
mouse system (Samavarchi-Tehrani et al., 2010). Interestingly,
analysis of mRNA expression indicates that a significant propor-
tion of reprogramming regulators remain unchanged during
reprogramming (Table S2). This supports a previous study re-
porting that 53% to 70% of the identified regulators remain
transcriptionally stable during mouse reprogramming (Yang
et al., 2014).
Among the repressors identified, the effect on reprogramming
was strongest when SMAD3, SFRS11, ZMYM2, ESET, or SAE1
were depleted. These repressors represent functionally distinct
regulators of unique pathways. The simultaneous removal of
these repressors had a cumulative and maximal effect on
improving reprogramming efficiency and kinetics. In combina-
tion with the overexpression of LIN28 and small-molecule inhibi-
tion of TGF-b, up to 85% TRA-1-60+ cells can be detected at
28 d.p.i. Thus, we established that the simultaneous elimination
of these functionally distinct repressors allows reprogramming
to proceed synchronously in a near-deterministic manner with
accelerated kinetics.
Temporal proteomic profiling of cells undergoing reprogram-
ming indicated the robust upregulation of RNA processing fac-
tors during the early phase of reprogramming (Hansson et al.,
2012). Our genome-wide screen indicates that RNA processing
factors could functionally repress reprogramming (Figure S1H).
Among these RNA-binding proteins, SFRS11 was the strongest
repressor. Analysis of deep mRNA-seq samples at 8 d.p.i.Table S2). The knockdown of repressor genes accelerated the switch to a
blasts and H1 hESCs during reprogramming. d12T+ and d16T+ siRepressor
enes. siNT2 samples are boxed (light gray).
into categories consisting of genes expressed at the early (I), intermediate (II), or
also indicated. siNT2 samples are boxed (light gray).
chymal (TWIST1), and epithelial (EPCAM, KRT8) markers. Data shown are
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Figure 4. SFRS11 Regulates the Splicing of the Transcripts for Reprogramming Effector ZNF207
(A) Difference in exon inclusion levels of significant differential splicing events between siSFRS11 versus siNT and siSMAD3 versus siNT. Heatmap color scale
ranges from white (no change in inclusion level) to red (large difference in inclusion level).
(legend continued on next page)
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revealed that 489 genes are alternatively spliced when SFRS11
was transiently depleted (Table S3). Interestingly, these genes
were enriched for biological functions associated with mRNA
splicing (MBNL1, SFRS3, U2AF1, SFRS2, and PUF60). MBNL1
was previously shown to regulate the splicing of a pluripotency
switch (FOXP1) in hESCs (Han et al., 2013) and was also identi-
fied as repressor from our genome-wide screen (Figure 1B). The
mouse homologs for SFRS3 and U2AF1 were previously identi-
fied as regulators of mouse reprogramming (Ohta et al., 2013).
This strongly suggests that SFRS11 could regulate reprogram-
ming through the splicing of downstream pluripotent-specific
splicing factors (Figure 4N).
Our study identified ZNF207 as one of the effectors of human
reprogramming. SFRS11 depletion during reprogramming in-
duces the isoform switch of ZNF207 B to A and C. The identifica-
tion of ZNF207 and other SFRS11-regulated splicing events
highlights an extensive role for the alternative splicing network
during reprogramming (Figure 4N). While SFRS11 repression en-
hances reprogramming by at least 5-fold (Figure 1F), overex-
pression of ZNF207 isoform C enhances reprogramming by
1.5-fold. It is highly possible that other SFRS11-regulated
splicing events are contributing to its role as a reprogramming
repressor. The functional significance of other SFRS11-regu-
lated splicing variants remains to be validated in the reprogram-
ming context.
Our study demonstrates that the regulation of a multiphasic
process, such as reprogramming, involve distinct regulators
that are involved in multiple pathways. Together, our systematic
and transient siRNA screen provides a wealth of information
about the functional regulators required specifically at the early
phase of reprogramming. These regulators may not have been
uncovered with the complete depletion of gene function using(B) MA plots of the de novo assembled transcripts in siSFRS11 versus siNT and
(C) GO analysis of genes differentially spliced by SFRS11 shows the enrichment o
represents the enrichment score (log10(p-value)) of the ontology term.
(D) Sashimi plots demonstrating the differential splicing events occurring at the ind
histogram indicate the number of readsmapped to the corresponding junction. Ex
(HMGA3), and 50 alternative splicing (ZNF462) are shown.
(E) Analysis of exon-skipping events after depletion of SFRS11. 434 events were id
SFRS11 resulted in the increase of exon inclusion (310 events, gray) as compare
(F) Analysis of mutually exclusive events after depletion of SFRS11. 114 events w
refers to the upstream exon that was included, while exon 2 refers to the down
inclusion of the downstream exon (72 events) as compared to upstream exon in
(G) Validation of alternative splicing events during reprogramming using PCR pri
whereas bottom panels illustrate mutually exclusive events.
(H) Regulation of ZNF207 isoforms by SFRS11. Depletion of SFRS11 resulted in in
isoform A and C. n = 4; error bars indicate SD.
(I) Overexpression of SFRS11 WT and mutant constructs decreases reprogramm
(J) SFRS11 binds to endogenous ZNF207 transcripts. CLIP-qPCR of BJ fibrob
showing enrichment for ZNF207 transcripts. Binding of the ZNF207 transcript is
(K) Gel electrophoresis analysis of CLIP-qPCR. Detection of ZNF207 transcript wa
BJ fibroblast cells.
(L) Overexpression of ZNF207 isoforms isoform A and C enhanced reprogramm
indicate SD. *p < 0.05, **p < 0.01, ***p < 0.001.
(M) Antisense oligonucleotides (AONs) induce ZNF207 exon skipping, which in tur
control. AON 1 and 2 induced exon skipping of ZNF207 exon 6, resulting in the iso
the isoform switch of C to B. n = 3; error bars indicate SD. ****p < 0.0001. Refer
(N) Proposed model illustrating the role of SFRS11 in the regulation of reprogram
enriched are boxed. SFRS11 regulates splicing of both unknown and previously
MBNL1, and PPARG.gene knockout or constitutive shRNA knockdown (Qin et al.,
2014; Yang et al., 2014). Taken together, these findings highlight
the need to transiently generate hypomorphic states of gene
expression in order to functionally dissect multi-phasic somatic
cell reprogramming.
EXPERIMENTAL PROCEDURES
Transfection, Staining, and Imaging in 384-Well Plates
Plates (384-well, Grenier) were coated with 15 ml Matrigel (BD) overnight at
37C. siRNA (2.5 ml 500 nM siGENOME, Dharmacon) was added to the plates,
which were then frozen at 20C before use. For reverse transfection, a mas-
ter mix of 0.04 ml DharmaFECT1 (Dharmacon) transfection reagent and 7.46 ml
OptiMEM (Invitrogen) mix was added to each well of the 384-well plates con-
taining the siRNA. 5 days post-OSKM, the DharmaFECT1 and siRNA mix was
incubated for 20 min before 4,000 BJ fibroblasts were seeded in each well in
40 ml MEF medium.
For the genome-wide screen, thewhole-genomeDharmaconSMARTpooled
siRNA library targeting 21,121 human geneswas printed on 67Matrigel-coated
384-well plates, where eachwell contained amixture of four siRNAs targeting a
single gene. On each plate, we included negative controls (non-target siRNA)
and positive controls (ESET siRNA and OCT4 siRNA) in the designated wells.
These controls were chosen because they are known to play an important
role in somatic cell reprogramming; OCT4 (Park et al., 2008; Takahashi and Ya-
manaka, 2006; Takahashi et al., 2007; Yu et al., 2007) is indispensable in most
reprogramming assays, andESET (Chen et al., 2013; Soufi et al., 2012) is awell-
established barrier of reprogramming. Medium was changed every other day
for 6 days. Subsequently, cells were washed once with PBS and fixed with
50 ml 4% paraformaldehyde (Sigma) for 20 min. Cells were then washed twice
before 25 ml anti-human TRA-1-60 antibody (1:300, BD #560173) was added,
and cells were incubated at 4Covernight. Hoechst 3342 (1:20,000, Invitrogen)
was added to each well and stained for 30 min. The cells were then washed
once with PBS and covered in 50 ml PBS.
Cells were imaged with an IXU ultra plate-scanning confocal microscope
(Molecular Devices) at 310 magnification, and nine pictures were taken per
well. Images obtained from multiple sites were combined to generate asiSMAD3 versus siNT.
f the indicated biological processes (top) and protein domains (bottom). x axis
icated genes. y axis represents the RPKM of the reads. The numbers within the
on skipping (ZNF207), mutually exclusive splicing (MTA1), 50 alternative splicing
entified to have an FDR < 0.01 when compared to siNT control. Knockdown of
d to exon exclusion (124 events, blue).
ere identified to have an FDR < 0.01 when compared to siNT control. Exon 1
stream exon that was included. Knockdown of SFRS11 resulted in increased
clusion (42 events).
mers flanking alternatively spliced exons. Top panels illustrate exon skipping,
creased retention of ZNF207 exon 9 and subsequent switching of isoform B to
ing efficiency. n = 3; error bars indicate SD. *p < 0.05.
lasts overexpressing WT-SFRS11-HA, but not DRRM-SFRS11-HA, construct
dependent on the RNA-recognition motif (RRM). n = 3; error bars indicate SD.
s only possible with the pull-down ofWT-SFRS11-HA protein in reprogramming
ing, while the expression of isoform B impeded the process. n = 3; error bars
n results in reduced reprogramming efficiency. scrAON is a scrambled negative
form switch of C to A. AON 3–5 induce skipping of ZNF207 exon 9, resulting in
to Table S4 for sequences.
ming-specific alternative splicing. Biological processes that are significantly
reported reprogramming regulators, including ZNF207, DNMT1, MTA1, HIRA,
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montage of different panels. Granule area, integrated fluorescent intensity,
and nuclei number were quantified using MetaXpress Image Acquisition
and Analysis software V2. The Z score was calculated using the formula
Z = (Xm)/SD, wherem is themean of negative control and SD is the standard
deviation of the whole population. X is the sample value calculated based on
TRA-1-60+ area per number of cells. For further analysis, we excluded genes
that reduced cell number by <50% of the average cell number per well in each
plate. This was done to remove false-positive candidates that affected cell
viability.
More details on production of viral supernatant, reprogramming assay, cell
culture, differentiation of iPSC clones, immunostaining, RNA extraction, RNA
sequencing, ChIP sequencing, AON transfection, microarray data, differential
GO analysis, enrichment analysis, GSEA, and other procedures can be found
in Supplemental Experimental Procedures.
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